Fundamentals · CRWV
Growth Metrics for CRWV
AI-generated plain-English read of growth metrics for CRWV. Updated daily.
Hyper-growth, decelerating
moderateRevenue is still hyper-growth (167.9% YoY) but the pace is cooling from 1041.4% — deceleration from hyper-growth is normal but the market will reprice the multiple; watch whether this is a return to sustainable high-growth or the start of a longer glide-down.
What will probably happen
- Growth is decelerating — without a reversal catalyst, the next quarter is likely to show further moderation in the top line.
- Highly erratic growth pattern — quarter-to-quarter volatility makes forecasting unreliable and reduces the quality of any single-period read.
What to do
- If you HOLD this stock
- Growth profile is intact but not compelling enough to add aggressively. Hold at current size and monitor the next quarterly print closely.
- If you're EVALUATING this stock
- Wait for stabilization — entering into a decelerating growth story adds more risk than the valuation discount typically compensates for. Look for one quarter of stabilization before initiating.
- If you trade OPTIONS
- No sharp growth signal either way. Sell premium (covered calls or cash-secured puts) into the stable-growth backdrop rather than positioning directionally on growth alone.
4 periods of income data — directionally informative but use more history for conviction.
Technical details
Technical analysis
- Trajectory
- Decelerating
- FCF YoY growth
- —
- Income periods
- 4
- Consistency tier
- Erratic
- Earnings quality
- In Line
- Latest data date
- 2025-12-31 00:00:00
- Cash flow periods
- 4
- Revenue YoY growth
- 167.9%
- Earnings YoY growth
- —
- Revenue growth tier
- Hyper
- Growth consistency (CV)
- 0.79
- Prior-avg revenue growth (2y)
- 1041.4%
Key levels
| Level | Value |
|---|---|
| cv revenue | 0.786 |
| revenue yoy | 1.679 |
| watch growth rate | 1.679 |
| prior avg rev growth | 10.414 |
Caveats
- Growth comparisons can be skewed by acquisitions, divestitures, or one-off items. Cross-check organic growth disclosures.